Carregant...
Current treatment options of brain metastases and outcomes in patients with malignant melanoma
The prognosis for patients with melanoma who have brain metastases is poor, a median survival does not exceed 4–6 months. There are no uniform standards of treatment for patients with melanoma brain metastases (MBMs). The most preferred treatment approaches include local therapy – surgical resection...
Guardat en:
| Publicat a: | Rep Pract Oncol Radiother |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5002030/ https://ncbi.nlm.nih.gov/pubmed/27601961 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rpor.2015.12.001 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|